SynerGenetics Bioscience

About:

SynerGenetics Bioscience is a plant genetics research and development company focused on developing high-yield CBD hemp strains/seeds.

Website: https://www.sgbioscience.com

Description:

SynerGenetics Bioscience Inc. is a Canadian plant genetics research and development company focused on developing high-yield CBD hemp strains/seeds. The Company is led by a management team with combined 35+ years of cannabis/hemp industry experience and a clear vision of capitalizing on the growing hemp and CBD markets. SG’s R&D team successfully utilized proprietary technology to identify desirable plant traits to create hemp strains yielding 12%+ CBD content to address commercial hemp farming problems. With yields averaging less than 7% on many strains used by hemp farmers, the 5% difference is material – both financially and quality wise.

Total Funding Amount:

$6M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2019-01-01

Contact Email:

info(AT)sgbioscience.com

Founders:

Johnson Ping Zhang

Number of Employees:

1-10

Last Funding Date:

2020-03-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai